Patterns of relapse following surgery and postoperative intensity modulated radiotherapy for oral and oropharyngeal cancer

Acta Oncologica

Volumn 50, Issue 7, 2011, Pages 1119-1125

  Collan, Juhani ^a   Lundberg, Marie ^a   Vaalavirta, Leila ^a   Bäck, Leif ^a   Kajanti, Mikael ^a   Mäkitie, Antti ^a   Tenhunen, Mikko ^a   Saarilahti, Kauko ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CISPLATIN; NON OPIOID ANALGESIC; OPIATE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CYTOPENIA; DEHYDRATION; DISTANT METASTASIS; DYSPHAGIA; ENDOSCOPY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INFECTION; INTENSITY MODULATED RADIATION THERAPY; KIDNEY FAILURE; LOCAL SKIN REACTION; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NEUTROPENIC INFECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OROPHARYNX CANCER; OVERALL SURVIVAL; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PHONATION; POSTOPERATIVE INFECTION; POSTOPERATIVE NAUSEA; PRIORITY JOURNAL; RADIATION DOSE; RELAPSE; SIDE EFFECT; SKIN PAIN; SKIN TOXICITY; SPEECH DISORDER; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; TUMOR VOLUME; XEROSTOMIA;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COHORT STUDIES; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; OROPHARYNGEAL NEOPLASMS; RADIOTHERAPY, INTENSITY-MODULATED; RECURRENCE; TIME FACTORS;

EID: 80052872084     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2010.549839     Document Type: Article

References (17)

1. Pignon JP, le Maitre A, Bourhis J. Meta-Analyses of Chemotherapy in Head and Neck Cancer (MACH-NC): An update. Int J Radiat Oncol Biol Phys 2007;69(2 Suppl): S12-S114.
2. Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefebvre JL, Greiner RH, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004;350:1945-52. (Pubitemid 38580197)
3. Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004;350:1937-44.
4. Saarilahti K, Kouri M, Collan J, Hamalainen T, Atula T, Joensuu H, et al. Intensity modulated radiotherapy for head and neck cancer: Evidence for preserved salivary gland function. Radiother Oncol 2005;74:251-8. (Pubitemid 40349134)
5. Saarilahti K, Kouri M, Collan J, Kangasmaki A, Atula T, Joensuu H, et al. Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer. Radiother Oncol 2006;78:270-5.
6. Fakhry C, Gillison M. clinical implications of human papillomavirus in head and neck cancer. J Clin Oncol 2006; 24:2606-11. (Pubitemid 46622080)
7. Pigott K, Dische S, Saunders MI. Where exactly does failure occur after radiation in head and neck cancer? Radiother Oncol 1995;37:17-9.
8. Daly ME, Le QT, Maxim PG, Loo BW, Jr., Kaplan MJ, Fischbein NJ, et al. Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: Clinical outcomes and patterns of failure. Int J Radiat Oncol Biol Phys 2010;76: 1339-46.
9. Roesink JM, Moerland MA, Battermann JJ, Hordijk GJ, Terhaard CH. Quantitative dose-volume response analysis of changes in parotid gland function after radiotherapy in the head-and-neck region. Int J Radiat Oncol Biol Phys 2001; 51:938-46. (Pubitemid 33026423)
10. Eisbruch A, Ten Haken RK, Kim HM, Marsh LH, Ship JA. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 1999;45:577-87. (Pubitemid 29462636)
11. Glanzmann C, Gratz KW. Radionecrosis of the mandibula: A retrospective analysis of the incidence and risk factors. Radiother Oncol 1995;36:94-100.
12. Murray CG, Herson J, Daly TE, Zimmerman S. Radiation necrosis of the mandible: A 10 year study. Part I. Factors infl uencing the onset of necrosis. Int J Radiat Oncol Biol Phys 1980;6:543-8. (Pubitemid 10065001)
13. Studer G, Studer SP, Zwahlen RA, Huguenin P, Gratz KW, Lutolf UM, et al. Osteoradionecrosis of the mandible: Minimized risk profi le following intensity-modulated radiation therapy (IMRT). Strahlenther Onkol 2006;182:283-8.
14. Borggreven PA, Verdonck-de Leeuw I, Rinkel RN, Langendijk JA, Roos JC, et al. Swallowing after major surgery of the oral cavity or oropharynx: A prospective and longitudinal assessment of patients treated by microvascular soft tissue reconstruction. Head Neck 2007;29:638-47. (Pubitemid 47168234)
15. Caudell JJ, Schaner PE, Meredith RF, Locher JL, Nabell LM, Carroll WR, et al. Factors associated with long-term dysphagia after defi nitive radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2009;73: 410-5.
16. Poulsen MG, Riddle B, Keller J, Porceddu SV, Tripcony L. Predictors of acute grade 4 swallowing toxicity in patients with stages III and IV squamous carcinoma of the head and neck treated with radiotherapy alone. Radiother Oncol 2008;87:253-9.
17. Eisbruch A, Schwartz M, Rasch C, Vineberg K, Damen E, Van As CJ, et al. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: Which anatomic structures are affected and can they be spared by IMRT? Int J Radiat Oncol Biol Phys 2004;60:1425-39. (Pubitemid 39601860)